Analyzing HLS Therapeutics (OTCMKTS:HLTRF) and Jupiter Wellness (NASDAQ:JUPW)

Jupiter Wellness (NASDAQ:JUPW) and HLS Therapeutics (OTCMKTS:HLTRF) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, valuation, earnings, analyst recommendations, risk and institutional ownership.

Earnings & Valuation

This table compares Jupiter Wellness and HLS Therapeutics”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jupiter Wellness	$5.96 million	3.45	-$15.22 million	($0.55)	-1.36
HLS Therapeutics	N/A	N/A	N/A	N/A	N/A

HLS Therapeutics has lower revenue, but higher earnings than Jupiter Wellness.

Profitability

This table compares Jupiter Wellness and HLS Therapeutics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Jupiter Wellness	-210.13%	-211.48%	-117.20%
HLS Therapeutics	N/A	N/A	N/A

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Jupiter Wellness and HLS Therapeutics, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jupiter Wellness	0	0	0	0	0.00
HLS Therapeutics	0	1	0	0	2.00

HLS Therapeutics has a consensus target price of $5.00, indicating a potential upside of 97.63%. Given HLS Therapeutics’ stronger consensus rating and higher possible upside, analysts plainly believe HLS Therapeutics is more favorable than Jupiter Wellness.

Institutional & Insider Ownership

15.6% of Jupiter Wellness shares are owned by institutional investors. 32.9% of Jupiter Wellness shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

HLS Therapeutics beats Jupiter Wellness on 5 of the 8 factors compared between the two stocks.

About Jupiter Wellness

Jupiter Wellness, Inc., a wellness company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women's sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as CBD Brands, Inc. Jupiter Wellness, Inc. was incorporated in 2018 and is headquartered in Jupiter, Florida.

About HLS Therapeutics

HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. The company's product portfolio includes Clozaril, an atypical antipsychotic for management of symptoms of treatment-resistant schizophrenia; and Vascepa, an icosapent ethyl capsules for cardiovascular disease. It also distributes MyCare psychiatry lab assays; and MyCare Insite, a point-of-care device to measure patient drug levels. In addition, the company holds the Canadian rights of Trinomia, a cardiovascular therapeutic; and a portfolio of royalty interests of four healthcare products. HLS Therapeutics Inc. is headquartered in Etobicoke, Canada.